Characterization of the nocardiopsin biosynthetic gene cluster reveals similarities to and differences from the rapamycin and FK-506 pathways.
about
Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate L-pipecolic acid in Escherichia coli.Synergism between genome sequencing, tandem mass spectrometry and bio-inspired synthesis reveals insights into nocardioazine B biogenesis.Structural Basis for Recognition of L-lysine, L-ornithine, and L-2,4-diamino Butyric Acid by Lysine Cyclodeaminase.
P2860
Characterization of the nocardiopsin biosynthetic gene cluster reveals similarities to and differences from the rapamycin and FK-506 pathways.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Characterization of the nocard ...... rapamycin and FK-506 pathways.
@en
type
label
Characterization of the nocard ...... rapamycin and FK-506 pathways.
@en
prefLabel
Characterization of the nocard ...... rapamycin and FK-506 pathways.
@en
P2093
P2860
P356
P1433
P1476
Characterization of the nocard ...... rapamycin and FK-506 pathways.
@en
P2093
Amy L Lane
Dana M Bis
Elle D James
Norah Alqahtani
Rajesh Viswanathan
Yang H Ban
P2860
P304
P356
10.1002/CBIC.201500007
P577
2015-03-05T00:00:00Z